Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (6): 575-578.doi: 10.35541/cjd.20210457
• Reviews • Previous Articles
Feng Mengdi, Wang Wenqing
Received:
2021-06-21
Revised:
2021-11-02
Online:
2024-06-15
Published:
2024-06-03
Contact:
Wang Wenqing
E-mail:wwqbio@163.com
Feng Mengdi, Wang Wenqing. Regulatory roles of transcription factors and receptors in the pathogenesis of acne[J]. Chinese Journal of Dermatology, 2024, 57(6): 575-578.doi:10.35541/cjd.20210457
[1] | 中国痤疮治疗指南专家组. 中国痤疮治疗指南(2019修订版)[J]. 临床皮肤科杂志, 2019,48(9):583⁃588. doi: 10.16761/j.cnki.1000⁃4963.2019.09.020. |
[2] | Yang S, Fang F, Yu X, et al. Knockdown of H19 inhibits the pathogenesis of acne vulgaris by targeting the mir⁃196a/TLR2/NF⁃κB axis[J]. Inflammation, 2020,43(5):1936⁃1947. doi: 10.1007/s10753⁃020⁃01268⁃z. |
[3] | Fernández JR, Webb C, Rouzard K, et al. SIG1459: a novel phytyl⁃cysteine derived TLR2 modulator with in vitro and clinical anti⁃acne activity[J]. Exp Dermatol, 2018,27(9):993⁃999. doi: 10.1111/exd.13692. |
[4] | 樊莎莎, 丁杨, 方慧倩, 等. 痤疮患者血清中多态上皮黏液素和TolL样受体信号表达活化与患者病情的关系[J]. 中国卫生检验杂志, 2020,30(12):1476⁃1478. |
[5] | Suvanprakorn P, Tongyen T, Prakhongcheep O, et al. Establishment of an anti⁃acne vulgaris evaluation method based on TLR2 and TLR4⁃mediated interleukin⁃8 production[J]. In Vivo, 2019,33(6):1929⁃1934. doi: 10.21873/invivo.11687. |
[6] | Suvanprakorn P, Tongyen T, Prakhongcheep O, et al. Establishment of an anti⁃acne vulgaris evaluation method based on TLR2 and TLR4⁃mediated interleukin⁃8 production[J]. In Vivo, 2019,33(6):1929⁃1934. doi: 10.21873/invivo.11687. |
[7] | El⁃Tahlawi S, Ezzat Mohammad N, Mohamed El⁃Amir A, et al. Survivin and insulin⁃like growth factor⁃I: potential role in the pathogenesis of acne and post⁃acne scar[J]. Scars Burn Heal, 2019,5:20595131 18818031. doi: 10.1177/2059513118818031. |
[8] | Briganti S, Flori E, Mastrofrancesco A, et al. Acne as an altered dermato⁃endocrine response problem [J]. Exp Dermatol, 2020, 29(9): 833⁃839, doi:10.1111/exd.14168. |
[9] | Behrangi E, Rasi A, Navid P, et al. Serum level of insulin⁃like growth factor 1 in patients with acne vulgaris versus healthy subjects[J]. J Skin Stem Cell, 2018,5(3):e79784. doi: 10.5812/jssc.79784. |
[10] | Rodighiero E, Bertolani M, Saleri R, et al. Do acne treatments affect insulin⁃like growth factor⁃1 serum levels? A clinical and laboratory study on patients with acne vulgaris[J]. Dermatol Ther, 2020,33(3):e13439. doi: 10.1111/dth.13439. |
[11] | Rahaman S, De D, Handa S, et al. Association of insulin⁃like growth factor (IGF)⁃1 gene polymorphisms with plasma levels of IGF⁃1 and acne severity[J]. J Am Acad Dermatol, 2016,75(4):768⁃773. doi: 10.1016/j.jaad.2016.05.019. |
[12] | Zinati⁃Saeed S, Shakiba E, Rahimi Z, et al. The insulin⁃like growth factor⁃1 (G>A) and 5,10⁃methylenetetrahydrofolate reductase (C677T) gene variants and the serum levels of insulin⁃like growth factor⁃1, insulin, and homeostasis model assessment in patients with acne vulgaris[J]. Iran J Pathol, 2020,15(1):23⁃29. doi: 10.30699/IJP.2019.105695.2098. |
[13] | Ceruti JM, Leirós GJ, Balañá ME. Androgens and androgen receptor action in skin and hair follicles[J]. Mol Cell Endocrinol, 2018,465:122⁃133. doi: 10.1016/j.mce.2017.09.009. |
[14] | Bansal P, Sardana K, Sharma L, et al. A prospective study examining isolated acne and acne with hyperandrogenic signs in adult females[J]. J Dermatolog Treat, 2021,32(7):752⁃755. doi: 10.1080/09546634.2019.1708245. |
[15] | Demirkan S, Sayın DB, Gündüz Ö. CAG polymorphism in the androgen receptor gene in women may be associated with nodulocystic acne[J]. Postepy Dermatol Alergol, 2019,36(2):173⁃176. doi: 10.5114/ada.2019.84592. |
[16] | Bharti S, Vadlamudi HC. A strategic review on the involvement of receptors, transcription factors and hormones in acne pathogenesis[J]. J Recept Signal Transduct Res, 2021,41(2):105⁃116. doi: 10.1080/10799893.2020.1805626. |
[17] | El⁃Hamd MA, El Taieb MA, Ibrahim HM, et al. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin[J]. J Cosmet Dermatol, 2019,18(1):16⁃20. doi: 10.1111/jocd.12503. |
[18] | Umar M, Sastry KS, Al Ali F, et al. Vitamin D and the pathophysiology of inflammatory skin diseases[J]. Skin Pharmacol Physiol, 2018,31(2):74⁃86. doi: 10.1159/000485132. |
[19] | Swelam MM, El⁃Barbary R, Saudi WM, et al. Associations among two vitamin D receptor (VDR) gene polymorphisms (ApaI and TaqI) in acne vulgaris: a pilot susceptibility study[J]. J Cosmet Dermatol, 2019,18(4):1113⁃1120. doi: 10.1111/jocd.12781. |
[20] | Kemeriz F, Tuncer SÇ, Acar EM, et al. Evaluation of 25⁃hydroxy vitamin D levels and disease severity in patients with acne vulgaris[J]. Dermatol Ther, 2020,33(3):e13393. doi: 10.1111/dth.13393. |
[21] | Ahmed Mohamed A, Salah Ahmed E M, Abdel⁃Aziz R T A, et al. The impact of active vitamin D administration on the clinical outcomes of acne vulgaris [J]. J Dermatolog Treat, 2020:1⁃6. doi:10.1080/09546634.2019.1708852. |
[22] | Al⁃Taiar A, Alkhabbaz M, Rahman A, et al. Plasma 25⁃hydroxy vitamin D is not associated with acne vulgaris[J]. Nutrients, 2018,10(10):15⁃25, doi:10.3390/nu10101525. |
[23] | Kassir M, Karagaiah P, Sonthalia S, et al. Selective RAR agonists for acne vulgaris: a narrative review[J]. J Cosmet Dermatol, 2020,19(6):1278⁃1283. doi: 10.1111/jocd.13340. |
[24] | Gericke J, Ittensohn J, Mihály J, et al. Regulation of retinoid⁃mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin[J]. PLoS One, 2013,8(4):e62643. doi: 10.1371/journal.pone.0062643. |
[25] | Blume⁃Peytavi U, Fowler J, Kemény L, et al. Long⁃term safety and efficacy of trifarotene 50 μg/g cream, a first⁃in⁃class RAR⁃γ selective topical retinoid, in patients with moderate facial and truncal acne[J]. J Eur Acad Dermatol Venereol, 2020,34(1):166⁃173. doi: 10.1111/jdv.15794. |
[26] | Kim JM, Choo JE, Lee HJ, et al. Epidermal growth factor attenuated the expression of inflammatory cytokines in human epidermal keratinocyte exposed to Propionibacterium acnes[J]. Ann Dermatol, 2018,30(1):54⁃63. doi: 10.5021/ad.2018.30.1.54. |
[27] | Lichtenberger BM, Gerber PA, Holcmann M, et al. Epidermal EGFR controls cutaneous host defense and prevents inflammation[J]. Sci Transl Med, 2013,5(199):199ra111. doi: 10.1126/scitranslmed.3005886. |
[28] | Kim HK, Yeo IK, Li K, et al. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double⁃blinded, placebo⁃controlled, split⁃face trial[J]. Int J Dermatol, 2014,53(8):1031⁃1036. doi: 10.1111/ijd.12488. |
[29] | Aydingoz IE, Tukenmez Demirci G, Agirbasli D, et al. The investigation of the amounts and expressions of epidermal growth factor, epidermal growth factor receptor, and epidermal growth factor receptor gene polymorphisms in acne vulgaris[J]. J Cosmet Dermatol, 2021,20(1):346⁃351. doi: 10.1111/jocd.13498. |
[30] | 谷廷敏, 孙志刚, 牛星焘, 等. 创面愈合过程中表皮生长因子及其受体变化的临床研究[J]. 中华烧伤杂志, 2001,17(1):52⁃53. doi: 10.3760/cma.j.issn.1009⁃2587.2001.01.016. |
[31] | Gupta M, Mahajan VK, Mehta KS, et al. Peroxisome proliferator⁃activated receptors (PPARs) and PPAR agonists: the ′future′ in dermatology therapeutics?[J]. Arch Dermatol Res, 2015,307(9):767⁃780. doi: 10.1007/s00403⁃015⁃1571⁃1. |
[32] | Dozsa A, Mihaly J, Dezso B, et al. Decreased peroxisome proliferator⁃activated receptor γ level and signalling in sebaceous glands of patients with acne vulgaris[J]. Clin Exp Dermatol, 2016,41(5):547⁃551. doi: 10.1111/ced.12794. |
[33] | Elmongy NN, Shaker O. Expression of peroxisome proliferator activator receptor β/δ (PPARβ/δ) in acne vulgaris[J]. Eur J Dermatol, 2012,22(1):42⁃45. doi: 10.1684/ejd.2011.1575. |
[34] | Amr K, Abdel⁃Hameed M, Sayed K, et al. The Pro12Ala polymorphism of the gene for peroxisome proliferator activated receptor⁃gamma is associated with a lower Global Acne Grading System score in patients with acne vulgaris[J]. Clin Exp Dermatol, 2014,39(6):741⁃745. doi: 10.1111/ced.12394. |
[35] | Saeidi S, Chamaie⁃Nejad F, Ebrahimi A, et al. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: contribution to lipid and lipoprotein profile[J]. Adv Med Sci, 2018,63(1):147⁃151. doi: 10.1016/j.advms.2017.09.003. |
[36] | Shi G, Liao PY, Cai XL, et al. FoxO1 enhances differentiation and apoptosis in human primary keratinocytes[J]. Exp Dermatol, 2018,27(11):1254⁃1260. doi: 10.1111/exd.13775. |
[1] | Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression [J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664. |
[2] | Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594. |
[3] | Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378. |
[4] | Ju Qiang, Li Jiaqi. Acne vulgaris revisited: from pathogenesis to treatment strategies [J]. Chinese Journal of Dermatology, 2024, 57(4): 289-294. |
[5] | Li Jiaqi, Liang Mengchen, Wu Xinyi, Zhang Qiujing, Li Sitong, Mo Xiaohui, Ju Qiang. Staphylococcus epidermidis phylotypes in hair follicles in skin lesions of patients with moderate acne vulgaris: a preliminary study [J]. Chinese Journal of Dermatology, 2024, 57(4): 295-301. |
[6] | Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578. |
[7] | Wang Yukun, Liu Jie. Application of deep learning in non-neoplastic dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220660-e20220660. |
[8] | Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190. |
[9] | Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122. |
[10] | Guliziba·Tuersun, Qu Yuanyuan. New advances in the treatment of vitiligo with JAK-STAT inhibitors [J]. Chinese Journal of Dermatology, 2024, 57(1): 71-75. |
[11] | Zhong Jiemin, Shao Lei, Liang Yimin, Huang Qiongxiao, Xia Manqi, Liu Yumei. Comparative study on efficacy and safety of single microneedle radiofrequency versus photodynamic therapy in the treatment of inflammatory lesions of moderate to severe facial acne vulgaris [J]. Chinese Journal of Dermatology, 2023, 56(8): 751-755. |
[12] | Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723. |
[13] | Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558. |
[14] | Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462. |
[15] | Guo Weinan, Wang Junxia, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao. Clinical efficacy of autologous adipose-derived stem cell gel grafting in the treatment of depressed acne scars [J]. Chinese Journal of Dermatology, 2023, 0(3): 20210867-e20210867. |
|